{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:08:15Z","timestamp":1777590495121,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006058","name":"St. Baldrick's Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006058","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"the National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Brockport High School Leukemia Dance Marathon"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.leukres.2010.10.018","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T09:20:50Z","timestamp":1289640050000},"page":"800-807","source":"Crossref","is-referenced-by-count":7,"title":["Acute lymphoblastic leukemia cells that survive combination chemotherapy in vivo remain sensitive to allogeneic immune effects"],"prefix":"10.1016","volume":"35","author":[{"given":"Johan","family":"Jansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chiao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor I.","family":"Kuzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.10.018_bib0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukemia","volume":"354","author":"Pui","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.10.018_bib0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2006-02-002824","article-title":"Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study","volume":"108","author":"Bhojwani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbmt.2008.11.009","article-title":"Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease\/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse","volume":"15","author":"Pulsipher","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/sj.bmt.1705914","article-title":"Allogeneic transplantation for childhood ALL","volume":"41","author":"Mehta","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.bmt.1702555","article-title":"Donor leukocyte infusions in acute lymphocytic leukemia","volume":"26","author":"Collins","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0030","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0165","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00262-010-0889-y","article-title":"Differential gene expression in acute lymphoblastic leukemia cells surviving allogeneic transplant","volume":"59","author":"Shand","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2010.10.018_bib0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood-2006-01-0322","article-title":"Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2","volume":"108","author":"Flotho","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0045","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood-2005-07-2930","article-title":"The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia","volume":"107","author":"Holleman","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0050","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood-2004-11-4296","article-title":"Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia","volume":"106","author":"Holleman","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0055","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1182\/blood-2005-08-3305","article-title":"Cytochrome c-related caspase-3 activation determines treatment response and relapse in childhood precursor B-cell ALL","volume":"107","author":"Meyer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2006-08-038398","article-title":"Up-regulation of c-FLIPS+R upon CD40 stimulation is associated with inhibition of CD95-induced apoptosis in primary precursor B-ALL","volume":"110","author":"Troeger","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0065","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3324\/haematol.10675","article-title":"Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia","volume":"92","author":"Troeger","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.10.018_bib0070","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1182\/blood-2002-11-3612","article-title":"Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia","volume":"102","author":"Holleman","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0075","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0080","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbmt.2008.02.015","article-title":"High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A\/ARF mutations retain susceptibility to alloreactive T cells","volume":"14","author":"Young","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0085","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1182\/blood.V95.7.2426","article-title":"Immunization of allogeneic bone marrow transplant recipients with tumor cell vaccines enhances graft-versus-tumor activity without exacerbating graft-versus-host disease","volume":"95","author":"Anderson","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0090","first-page":"5797","article-title":"Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease","volume":"60","author":"Anderson","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2010.10.018_bib0095","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.bmt.1704021","article-title":"An analysis of immunodominance among minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Mori","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10428190290011976","article-title":"Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation","volume":"43","author":"Mullen","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2010.10.018_bib0105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/10428190500032596","article-title":"Cellular tumor vaccines administered after T cell-depleted allogeneic bone marrow transplantation induce effective anti-tumor immune responses","volume":"46","author":"Mundhada","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2010.10.018_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.leukres.2010.10.018_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejca.2005.09.017","article-title":"Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukemia","volume":"42","author":"Swerts","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.leukres.2010.10.018_bib0120","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1182\/blood-2002-11-3461","article-title":"The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype","volume":"102","author":"Steinbach","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.10.018_bib0125","first-page":"11","article-title":"Development of a double-drug-resistant human leukemia model to cytosine arabinoside and l-asparaginase: evaluation of cross-resistance to other treatment modalities","volume":"21","author":"Majlessipour","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.leukres.2010.10.018_bib0130","first-page":"2657","article-title":"Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias \u2013 correlation to the expression of multidrug resistance proteins","volume":"23","author":"Fichtner","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.leukres.2010.10.018_bib0135","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10495-009-0330-1","article-title":"Targeting p53 for enhanced radio- and chemo-sensitivity","volume":"14","author":"Lu","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.leukres.2010.10.018_bib0140","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1038\/sj.onc.1209326","article-title":"p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice","volume":"25","author":"Shank-Calvo","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2010.10.018_bib0145","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1038\/sj.onc.1209437","article-title":"The tumor suppressor p16Ink4a regulates T lymphocyte survival","volume":"25","author":"Bianchi","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.leukres.2010.10.018_bib0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.bbmt.2006.01.009","article-title":"Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering","volume":"12","author":"Ayello","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.leukres.2010.10.018_bib0155","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.164.3.814","article-title":"Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis","volume":"164","author":"Phillips","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.leukres.2010.10.018_bib0160","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2007.05.013","article-title":"A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4h 51Cr-release assay","volume":"325","author":"Kim","year":"2007","journal-title":"J Immunol Methods"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610005114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610005114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,13]],"date-time":"2020-06-13T20:06:06Z","timestamp":1592078766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610005114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0145212610005114"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.10.018","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}